In vivo optical signatures of neuronal death in a mouse model of Alzheimer's disease

There currently is a need for cost‐effective, quantitative techniques to evaluate the gradual progression of Alzheimer's disease (AD). Measurement techniques based on diffuse optical spectroscopy can detect blood perfusion and brain cellular composition changes, through measuring the absorption (µa) and reduced scattering (µs′) coefficients, respectively, using non‐ionizing near‐infrared light. Previous work has shown that brain perfusion deficits in an AD mouse model can be detected. The objective of this study was to determine if µs′ is sensitive to the inflammation and neuron death found in AD.

[1]  Bruce J Tromberg,et al.  Diffuse optical imaging using spatially and temporally modulated light. , 2012, Journal of biomedical optics.

[2]  D. Drachman.  Aging of the brain, entropy, and Alzheimer disease , 2006, Neurology.

[3]  B. Turan,et al.  Doxycycline Ameliorates Vascular Endothelial and Contractile Dysfunction in the Thoracic Aorta of Diabetic Rats , 2011, Cardiovascular Toxicology.

[4]  Anthony J. Durkin,et al.  Quantitation and mapping of tissue optical properties using modulated imaging. , 2009, Journal of biomedical optics.

[5]  A. Verkhratsky,et al.  Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease , 2010, Glia.

[6]  E. Salmon,et al.  18F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial , 2010, Annals of neurology.

[7]  B. Strooper,et al.  The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics , 2011, Nature Reviews Drug Discovery.

[8]  A. Ehlis,et al.  Simulation of Near-Infrared Light Absorption Considering Individual Head and Prefrontal Cortex Anatomy: Implications for Optical Neuroimaging , 2011, PloS one.

[9]  E. Reiman.  Fluorodeoxyglucose positron emission tomography: emerging roles in the evaluation of putative Alzheimer's disease-modifying treatments , 2011, Neurobiology of Aging.

[10]  Anthony J. Durkin,et al.  Modulated imaging: quantitative analysis and tomography of turbid media in the spatial-frequency domain. , 2005, Optics letters.

[11]  Irving J Bigio,et al.  Wavelength-dependent backscattering measurements for quantitative real-time monitoring of apoptosis in living cells. , 2009, Journal of biomedical optics.

[12]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[13]  L. Perelman,et al.  Scattering differentiates Alzheimer disease in vitro. , 2008, Optics letters.

[14]  Philip Scheltens,et al.  Imaging in Alzheimer's disease , 2009, Dialogues in clinical neuroscience.

[15]  Venkataramanan Krishnaswamy,et al.  Automated identification of tumor microscopic morphology based on macroscopically measured scatter signatures. , 2009, Journal of biomedical optics.

[16]  F. LaFerla,et al.  Neural Stem Cells Improve Memory in an Inducible Mouse Model of Neuronal Loss , 2007, The Journal of Neuroscience.

[17]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[18]  Bruce J. Tromberg,et al.  Spatial Frequency Domain Imaging of Intrinsic Optical Property Contrast in a Mouse Model of Alzheimer’s Disease , 2011, Annals of Biomedical Engineering.

[19]  W. Bowers,et al.  Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic mice , 2008, BMC Neuroscience.

[20]  A. Podtelezhnikov,et al.  Molecular Insights into the Pathogenesis of Alzheimer's Disease and Its Relationship to Normal Aging , 2011, PloS one.